NEW YORK, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Semtech Corp. (NASDAQ: SMTC) for potential violations of the federal securities laws. If you invested in Semtech , you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/semtech-corp.

NEW YORK, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Nextracker Inc. (NASDAQ: NXT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Nextracker, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/nextracker-inc.

NEW YORK, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Crocs, Inc. (NASDAQ: CROX) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Crocs, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/crocs-inc.

NEW YORK, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into The Trade Desk, Inc. (NASDAQ: TTD) for potential violations of the federal securities laws. If you invested in Trade Desk, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/the-trade-desk-inc.

CHICAGO--(BUSINESS WIRE)--Coeur Mining, Inc. (“Coeur”) (NYSE: CDE) is pleased to announce the completion of its acquisition of SilverCrest Metals Inc. (“SilverCrest”) by Coeur (the “Transaction”) pursuant to the definitive agreement (the “Agreement”) previously announced in the joint news release of Coeur and SilverCrest dated October 4, 2024. Under the terms of the Agreement, Coeur acquired all of the issued and outstanding common shares of SilverCrest, with SilverCrest shareholders receiving.

EDEN PRAIRIE, Minn., Feb. 14, 2025 (GLOBE NEWSWIRE) -- Winnebago Industries, Inc. (NYSE: WGO), a leading manufacturer of outdoor recreation products, announced today that Steve Speich will be joining the organization as senior vice president, enterprise operations, effective March 3, 2025.

Roku (ROKU) shares are jumping around 15% in premarket trading Friday, after the streaming company posted better-than-estimated fourth-quarter results.

I have a secret I want to share with you. Ever since DeepSeek broke on the world stage three weeks ago, and instantly subtracted $600 billion from Nvidia's (Nasdaq: NVDA) market capitalization, I've been eyeing the stock and wondering if I should “buy the dip”?

MGY is expected to report higher revenues and an improved bottom line in the fourth quarter, driven by increased production and effective cost management.

LONDON--(BUSINESS WIRE)--Perfect Moment Ltd. (NYSE American: PMNT), the high-performance, luxury skiwear and lifestyle brand that fuses technical excellence with fashion-led designs, has officially launched its new puffer tote bag and sunglass collection. The puffer bag collection was inspired by the intuitive ‘throw in & go' approach to packing of Perfect Moment's president and chief creative officer, Jane Gottschalk. These versatile jumbo padded totes are the ultimate companion for life o.

Cisco Systems NASDAQ: CSCO latest earnings report exceeded analyst expectations, indicating a potential resurgence for the technology company. As a result, Cisco's stock price rose to new yearly highs, and investor confidence was seemingly renewed.

- KOSTAIVE represents a significant advancement in vaccine technology, demonstrating superior immunogenicity and antibody persistence for up to 12 months post-vaccination compared to conventional mRNA COVID-19 vaccines in clinical trials WALTHAM, Mass. and SAN DIEGO , Feb. 14, 2025 /PRNewswire/ -- Global biotechnology leader CSL (ASX: CSL; USOTC: CSLLY) and sa-mRNA pioneer Arcturus Therapeutics (Nasdaq: ARCT) today announced that the European Commission has granted marketing authorization for KOSTAIVE ® (ARCT-154), a self-amplifying mRNA COVID-19 vaccine, for individuals 18 years and older.

Investing higher up in the capital structure of companies has its perks. Cumulative preferreds have demonstrated income resilience through serious headwinds and existential threats faced by issuers. We discuss our top preferred picks with well-covered dividends.

NEW YORK, NY / ACCESS Newswire / February 14, 2025 / If you suffered a loss on your Neumora Therapeutics, Inc. (NASDAQ:NMRA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/neumora-therapeutics-inc-lawsuit-submission-form?prid=129493&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 14, 2025 / If you suffered a loss on your Joint Stock Company Kaspi.kz (NASDAQ:KSPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/joint-stock-company-kaspi-kz-lawsuit-submission-form?prid=129494&wire=1 or contact Joseph E. Levi, Esq.

KINSTON, N.C. & LAS VEGAS--(BUSINESS WIRE)--flyExclusive Inc. (NYSE American: FLYX), a publicly traded provider of premium jet charter experiences, has entered a definitive agreement to acquire the aviation business of Jet.AI Inc. (NASDAQ: JTAI), an innovative private aviation and artificial intelligence company. flyExclusive will acquire the business in conjunction with Jet.AI's focus on being a pure-play AI solutions company. The transaction will occur following Jet.AI's spin of the business.

The Trade Desk's high valuation continues to create disappointment, despite the company's fundamentals remaining reasonably strong. The fourth quarter miss was attributed to execution issues, but it is not really clear what this means. While The Trade Desk has a strong business, it is maturing, meaning growth is likely to continue decelerating.

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)---- $VCYT--New Data at ASCO GU Show Power of Veracyte's Decipher Tests to Improve Patient Care and Its GRID Tool to Advance Prostate and Bladder Cancer Research.

QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH) (“Delcath” or the “Company”), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced an update to the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for the treatment of metastatic uveal melanoma (mUM). Our proprietary products, HEPZATO KIT™ (HEPZATO (melphalan) for Injection/Hepatic Delivery System.

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, announced today that it has closed on a $600 million senior secured revolving credit facility with a bank syndicate. "Sarepta's financial strength and the positive outlook for our business provide us with the flexibility to use non-dilutive financing by establishing a revolving credit facility. It supplements our strong balance sheet and allows for contingent.